Testosterone Enanthate: What the Drug Is and How It Works

Testosterone enanthate is one of the most widely used injectable forms of testosterone in the world. It is a legitimate medicine for men with testosterone deficiency and, separately, a drug long misused in sport. Our editorial team explains how the molecule is built, what happens to it in the body, where medicine ends, and where the risks begin.

What testosterone enanthate is

Testosterone enanthate is an ester of the natural male sex hormone testosterone and enanthic (heptanoic) acid. On its own, pure testosterone is cleared from the body within hours of an injection. Attaching a carbon chain, the ester, slows that process so the hormone can be given far less often.

The drug is supplied as an oil-based solution for intramuscular injection. The oily carrier forms a depot in the muscle from which the compound is released gradually into the bloodstream. This places enanthate among the medium-duration testosterone preparations, between short propionate and long undecanoate.

Pharmacologically, testosterone enanthate is a prodrug: enzymes called esterases cleave off the ester in the blood, after which ordinary testosterone, identical to what the testes produce, does the work. Every effect of the drug is therefore an effect of testosterone itself; the ester only governs the speed of release.

Esters of testosterone were first explored in the 1950s as a way to reduce how often patients with hormone deficiency needed injections. Enanthate proved a good compromise between duration and stability, and it remains on formularies for replacement therapy in the United States and many other countries.

How the ester changes the hormone's behavior

The defining property of an ester is its fat solubility. The longer the carbon chain, the more slowly the compound leaves the oily depot and enters the watery blood. With its seven-carbon chain, enanthate releases at a moderate pace, and blood testosterone typically peaks within the first few days after an injection before declining.

The elimination half-life of testosterone enanthate is estimated in the pharmacological literature at roughly four to five days. Under older replacement schedules that spaced injections two or three weeks apart, hormone levels swung from above normal just after a dose to below normal before the next, and patients often felt those swings as changes in mood, energy and libido.

Different esters behave differently, as the table below shows. The figures vary by source and individual and should be read as orders of magnitude, not precise values.

The ester does not make testosterone stronger or weaker; it only shapes the release profile. Because part of each milligram is the heavier ester, enanthate contains slightly less pure hormone per milligram than propionate, with roughly 72 percent of the mass being testosterone itself.

Mechanism of action in the body

Once the ester is removed, testosterone binds to androgen receptors inside cells, which act as switches for genes. The hormone-receptor complex moves into the nucleus and triggers the synthesis of specific proteins. In muscle, this increases production of contractile proteins and activates satellite cells that support fiber growth.

Part of the testosterone in tissues is converted to dihydrotestosterone by the enzyme 5-alpha-reductase. This more potent androgen drives effects in skin, hair follicles and the prostate, and is linked to acne and, in genetically predisposed men, accelerated hair loss.

Another portion is converted by the enzyme aromatase into estradiol. Estrogen in men is not an enemy; it is necessary for bone health, lipid metabolism, libido and brain function. Trouble arises when testosterone, and therefore estradiol, is pushed to supraphysiological levels, raising the risk of breast tissue growth and fluid retention.

A resource many readers return to is Boldenon.

A landmark randomized trial by Bhasin and colleagues, published in 1996, showed that high doses of enanthate increased lean body mass even without training, with the largest effect when combined with resistance exercise. Later work from the same group demonstrated that both anabolic effects and adverse changes, such as a drop in protective HDL cholesterol, were dose-dependent.

Approved medical uses

The principal medical indication for testosterone enanthate is male hypogonadism, a condition in which the body does not produce enough testosterone. The diagnosis requires both characteristic symptoms and consistently low hormone readings on several morning blood tests. Endocrine Society guidance explicitly advises against prescribing testosterone to men without confirmed deficiency.

The drug is also used to induce puberty in adolescents with delayed development under specialist supervision, in gender-affirming hormone therapy for transgender men, and in certain conditions involving muscle loss. A physician sets the dose and interval based on laboratory results; the aim is to restore the hormone to the mid-normal range, not to exceed it.

Patients on therapy are monitored regularly, with checks of testosterone, hematocrit, prostate-specific antigen where appropriate, lipids and blood pressure. This surveillance is what separates safe replacement from reckless use.

The large TRAVERSE trial, published in 2023, enrolled more than five thousand men with hypogonadism and high cardiovascular risk and found no increase in major cardiac events on therapeutic doses, though atrial fibrillation and pulmonary embolism were somewhat more common. These findings apply to medical doses and do not transfer to supraphysiological use.

Risks and side effects

Most risks of testosterone enanthate depend on dose and duration. Within medical prescribing they are controlled, but in self-directed sporting use the doses are often many times physiological, and the safety profile changes dramatically. We provide no doses or regimens for such use; the summary below describes documented hazards.

One of the least obvious yet most serious effects is suppression of the body's own hormone production, as external testosterone switches off pituitary signaling. The testes shrink and sperm production stops; in some men recovery takes many months, and a minority develop persistent hypogonadism.

For women, testosterone enanthate carries a risk of virilization, including voice deepening, facial hair growth and menstrual disruption, some of which is irreversible. And on the illicit market, product quality is uncertain: incorrect concentration, substitution or non-sterility can cause abscesses needing surgery.

Readers may also find our articles on undecanoate versus enanthate, on recovery of the hormonal system after androgen use, and on the blood tests used to monitor hormonal health relevant to this topic.

References

1. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335(1):1–7.
2. Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281(6):E1172–E1181.
3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744.
4. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107–117.
5. Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
6. Nieschlag E, Behre HM, Nieschlag S, eds. Testosterone: Action, Deficiency, Substitution. 4th ed. Cambridge University Press; 2012.